© 2021 MJH Life Sciences and HCPLive. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive. All rights reserved.
September 25, 2017
“We ought to learn as much as we can about what makes these persons unique so we can find more therapeutic options that can be expanded to a larger population.”
September 06, 2017
A study found that the demographic characteristics of patients who failed to initiate ART within 2 years of entering care were not as important as clinical factors.
September 05, 2017
The rates of viral rebound in people with long-term viral suppression on first-line regimens have become "extremely low," according to a study.
While the national split is a significant jump from previously reported rates, the degrees of the success vary in different parts of the country, Barry S. Zingman, MD, Medical Director, AIDS Center, Montefiore Health System, told MD Magazine.